TODD E SIMPSON
CIK 1216477 · Chief Financial Officer · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$484.8K
Companies
4
Total Filings
91
Lifetime Open-Market Net
-$93.80M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XNCR | Director | 23,988 | $20.21 | $484.8K | $0 | 3 | 2026-07-08 |
| Seagen Inc. (SGEN) Delisted | Chief Financial Officer | 0 | $228.74 | $0 | -$93.80M | 72 | 2023-12-15 |
| Neurogene Inc. (NLTX) Delisted | Director | — | $13.96 | — | $0 | 5 | 2023-06-09 |
| Neurogene Inc. (AQXP) Delisted | Director | — | — | — | $0 | 5 | 2018-05-09 |
Recent Filings · Page 5 of 10
91 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-07 | Neurogene Inc. (NLTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-06 | Seagen Inc. (SGEN) Delisted | Mixed | +12,192 | -$5.42M | EDGAR |
| 2020-04-21 | Seagen Inc. (SGEN) Delisted | Mixed | +3,258 | -$79.8K | EDGAR |
| 2019-12-23 | Seagen Inc. (SGEN) Delisted | Grant (A) | +871 | $0 | EDGAR |
| 2019-10-15 | Neurogene Inc. (NLTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-10-02 | Seagen Inc. (SGEN) Delisted | Sell (S) | −15,000 | -$1.27M | EDGAR |
| 2019-09-04 | Seagen Inc. (SGEN) Delisted | Mixed | +19,196 | -$148.1K | EDGAR |
| 2019-08-30 | Seagen Inc. (SGEN) Delisted | Sell (S) | −5,909 | -$432.6K | EDGAR |
| 2019-08-22 | Seagen Inc. (SGEN) Delisted | Sell (S) | −12,500 | -$1.00M | EDGAR |
| 2019-04-09 | Seagen Inc. (SGEN) Delisted | Sell (S) | −12,500 | -$975.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.